---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-117526"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2022-04-25T23:59:59+00:00"
generated_at: "2026-06-26T05:06:52.871877+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# GoodRx appoints Romin Nabiey as Chief Accounting Officer

## Summary
- Appointment effective April 20, 2022; Nabiey becomes principal accounting officer.
- Nabiey succeeds CFO Karsten Voermann, who remains principal financial officer.
- Nabiey has served at GoodRx since May 2017, most recently as SVP, Corporate Controller.
- No new compensation has been determined for Nabiey in connection with the appointment.

## SEC filing metadata
- accession: 0001193125-22-117526
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2022-04-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000119312522117526/0001193125-22-117526-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000119312522117526/d200437d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-117526
- JSON: https://secwatch.observer/filing/0001193125-22-117526.json
- Plain text: https://secwatch.observer/filing/0001193125-22-117526.txt

## Key facts
- Executive change
  Romin Nabiey was appointed as Chief Accounting Officer at GoodRx Holdings, Inc..
  - Action: appointed
  - Role: Chief Accounting Officer
  source text: On April 20, 2022, the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”) appointed Romin Nabiey, Senior Vice President, Corporate Controller of the Company as the Company’s Chief Accounting Officer and designated Mr. Nabiey as the principal accounting officer of the Company, in each case effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000119312522117526/0001193125-22-117526-index.htm
- Executive change
  Karsten Voermann changed role as Chief Financial Officer at GoodRx Holdings, Inc..
  - Action: succeeded
  - Role: Chief Financial Officer
  source text: Mr. Nabiey succeeds Karsten Voermann, the Company’s Chief Financial Officer, in such role.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000119312522117526/0001193125-22-117526-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.